Ureteroscope Market Size, Share & Trends Analysis Report By Product Type (Flexible Ureteroscopes, Semi-Rigid Ureteroscopes, Rigid Ureteroscopes), By Usage (Reusable Ureteroscopes, Single-Use Ureteroscopes), By Application (Urolithiasis (Kidney Stones), Urinary Stricture, Kidney Cancer, Others), By End-User (Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Diagnostic Centers, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Ureteroscope Market Size

The global ureteroscope market size was valued at USD 1.38 billion in 2025 and is projected to grow from USD 1.46 billion in 2026 to USD 2.26 billion by 2034, registering a CAGR of 5.62% during the forecast period from 2026 to 2034. North America dominated the ureteroscope market with a market share of 38.4% in 2025.

One of the key drivers of the global ureteroscope market is the rising prevalence of urolithiasis, driven by poor hydration, high salt intake, and sedentary lifestyles. According to the National Kidney Foundation, over 500,000 Americans visit emergency rooms annually due to kidney stones, with global prevalence reaching up to 15% in adults. This has increased the demand for effective and minimally invasive procedures like ureteroscopy.

Additionally, technological advancements such as miniaturization, improved deflection capabilities, and high-resolution imaging are enhancing procedural success rates and patient safety. Another significant driver is the quick expansion of healthcare infrastructure, especially in emerging nations like India and China, where governments are heavily investing in modern urology equipment. These factors, along with rising awareness about early diagnosis and treatment of urological disorders, are collectively propelling the growth of the global ureteroscope market.

Product Type Insights

Flexible ureteroscopes hold the largest market share due to their superior maneuverability and ability to access the upper urinary tract, making them ideal for treating complex kidney stones and other urological conditions. Their advanced digital visualization enhances diagnostic accuracy and procedural outcomes. The increasing demand for minimally invasive surgeries and rising adoption in both developed and emerging healthcare systems further support segment growth. Technological advancements and reduced postoperative complications also contribute to the widespread use of flexible ureteroscopes globally.

Request Customizationto receive a tailored report.

Usage Insights

Reusable ureteroscopes remain a preferred choice in the market due to their long-term cost-effectiveness and availability of high-quality, durable designs. Hospitals and specialty clinics with advanced sterilization facilities often invest in reusable devices to reduce per-procedure costs. Although maintenance and repair can be costly, these scopes offer superior imaging and flexibility for repeated use. Their widespread availability and familiarity among urologists further drive their continued adoption, especially in high-volume healthcare settings across both developed and emerging regions.

Application Insights

Urolithiasis, or kidney stone disease, dominates the application segment of the market, boosted by the rising global prevalence of kidney stones due to dietary changes, obesity, and dehydration. Ureteroscopy is a preferred treatment for its minimally invasive nature, particularly for stones in the ureter or kidney. Flexible and semi-rigid ureteroscopes offer effective stone visualization and removal, improving patient outcomes. The increasing recurrence rate of kidney stones further boosts the segment’s growth in this market.

End-User Insights

Hospitals lead the end-user segment due to their comprehensive infrastructure, skilled medical professionals, and ability to handle high volumes of urological procedures. They are primary adopters of technologically advanced ureteroscopes, including flexible and digital variants, due to access to better funding and sterilization capabilities. Hospitals also support both inpatient and outpatient procedures, making them a central hub for ureteroscopy. The presence of dedicated urology departments in tertiary hospitals further solidifies their dominance in the global market.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America: Dominant Region

The ureteroscope market in North America is witnessing robust growth due to a high incidence of urolithiasis, advanced healthcare infrastructure, and widespread adoption of minimally invasive surgeries. Strong reimbursement frameworks and high awareness among urologists have accelerated the uptake of flexible and digital ureteroscopes. Technological innovations, including single-use scopes and AI-integrated systems, are also rapidly entering clinical practice. Additionally, increasing outpatient procedures in ambulatory surgical centers and early adoption of robotic-assisted urology tools are contributing to regional market expansion.

• The U.S. ureteroscope market is driven by high rates of urolithiasis, with over 1 in 10 Americans developing kidney stones, according to the National Kidney Foundation. Advanced healthcare infrastructure and increased adoption of disposable and digital ureteroscopes support market growth. For instance, Boston Scientific’s LithoVue single-use digital ureteroscope is widely used across U.S. ambulatory surgical centers and hospitals, enhancing procedural efficiency and reducing infection risks.
• Canada’s ureteroscope industry benefits from growing investments in urological care and minimally invasive technologies. Rising kidney stone incidence, especially in Ontario and Alberta, is increasing demand for flexible ureteroscopes. The Canadian Urological Association supports digital transformation in urology, and hospitals like Toronto General Hospital are adopting state-of-the-art ureteroscopic tools. Government-funded healthcare also facilitates broader access to modern urological diagnostics and interventions across the country.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia-Pacific: Significantly Growing Region

Asia Pacific presents prominent growth potential due to improving healthcare access, increasing patient awareness, and the growing burden of kidney-related disorders. Rising investments in healthcare infrastructure and the rapid expansion of private hospitals are facilitating the adoption of advanced urology devices. Cost-effective manufacturing and rising local production of endoscopic instruments are helping to meet domestic demand. Additionally, training programs and partnerships with international medical device firms are enabling skill development and broader uptake of digital and single-use ureteroscopes across urban and semi-urban centers.

• China's ureteroscope market is witnessing rapid growth driven by a rising incidence of kidney stones, affecting over 10% of the adult population. Government-backed healthcare reforms, such as the "Healthy China 2030" initiative, are expanding access to advanced urological care. Companies like Olympus and Pusen Medical are increasing investments in digital and disposable ureteroscopes, catering to growing demand from urban hospitals and tier-2 cities alike.
• India's market for ureteroscope is expanding due to the increasing prevalence of urolithiasis, especially in northern and western regions. According to AIIMS, over 12% of India's population may experience kidney stones in their lifetime. The rise of private multi-specialty hospitals and day-care surgical centers like Fortis and Apollo is accelerating the adoption of flexible ureteroscopes. Additionally, Make in India initiatives are encouraging local manufacturing of cost-effective urological devices.

Europe: Substantial Potential for Growth

Europe’s market growth is driven by rising demand for minimally invasive procedures and favorable government support for advanced diagnostic equipment. Healthcare systems across the region are integrating high-definition imaging and disposable scopes to reduce infection risks and procedural time. The presence of various leading medical device manufacturers has facilitated faster innovation and distribution. Growing clinical trials in urology and standardized surgical guidelines have further promoted the adoption of flexible ureteroscopes in hospitals and specialty clinics, enhancing procedural outcomes and market penetration.

• Germany’s ureteroscope industry is driven by its advanced healthcare infrastructure and high incidence of urolithiasis, affecting over 5% of the population annually. The government’s emphasis on minimally invasive surgery is fueling demand for flexible ureteroscopes. For example, hospitals like Charité – Universitätsmedizin Berlin have adopted digital ureteroscopes for precise stone management, boosting procedural efficiency and patient outcomes.
• The UK ureteroscope market is expanding due to NHS investments in endourology and growing preference for outpatient procedures. With over 80,000 hospital admissions for kidney stones annually, the demand for ureteroscopes is rising. Institutions like Guy’s and St Thomas’ Hospital utilize single-use ureteroscopes to reduce infection risks and reprocessing costs, aligning with the UK’s emphasis on patient safety and cost containment.

Company Market Share

Companies in the ureteroscope market are focusing on product innovation, including the development of single-use and digital ureteroscopes to reduce infection risks and enhance imaging. They are also expanding their global footprint through strategic partnerships, acquisitions, and regional distribution networks. Investment in R&D for miniaturized and AI-integrated devices is on the rise, alongside efforts to offer training programs for urologists to increase adoption and procedure efficiency across various healthcare settings.

Olympus Corporation: Olympus Corporation is a leading player in the global ureteroscope market, renowned for its innovative endoscopic and urological solutions. Headquartered in Japan, the company offers a comprehensive range of flexible and rigid ureteroscopes equipped with advanced imaging technologies. Olympus is widely recognized for its VISERA ELITE II and URF-V series, which enhance diagnostic accuracy and procedural efficiency. With a strong global distribution network and consistent R&D investment, Olympus remains a dominant force in minimally invasive urological care.

• In September 2024, Olympus introduced the CH‑S700‑08‑LB, a 4K camera head for urological endoscopy compatible with the VISERA ELITE III system. It delivers four times the pixel count of HD, supporting 4K white‑light and Narrow Band Imaging (NBI), plus blue‑light visualization in one device. This enables sharper detection of bladder lesions and optimizes non‑muscle‑invasive bladder cancer diagnosis and treatment.

List of Key and Emerging Players in Ureteroscope Market